| Project/Area Number |
22700918
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Clinical oncology
|
|---|
| Research Institution | Hiroshima University |
|---|
Principal Investigator |
HAMAI Yoichi 広島大学, 病院, 病院助教 (90423384)
|
|---|
| Research Collaborator |
HIHARA Jun 広島大学, 原爆放射線医科学研究所, 講師 (10322744)
EMI Manabu 広島大学, 原爆放射線医科学研究所, 助教 (30464308)
AOKI Yoshiro 広島大学, 病院, 医科診療医 (70557074)
|
|---|
| Project Period (FY) |
2010 – 2011
|
| Project Status |
Completed (Fiscal Year 2011)
|
| Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2011: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2010: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
|---|
| Keywords | SELEX法 / RNAアプタマー / EGF / 分子標的薬 / 核酸治療 |
|---|
| Research Abstract |
The biotin tagged epidermal growth factor (EGF) protein was made. The specific RNA aptamer for EGF protein was identified and acquired from synthetic oligonucleotide with random-sequence by systematic evolution of ligands by exponential enrichment (SELEX) method using the biotin tagged EGF protein. This anti-EGF aptamer could interfere with the binding of EGF to the receptor.
|
